These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 37752496)

  • 1. Treat-to-target strategies for the management of familial Mediterranean Fever in children.
    Ehlers L; Rolfes E; Lieber M; Müller D; Lainka E; Gohar F; Klaus G; Girschick H; Hörstermann J; Kümmerle-Deschner J; Brunner J; Palm-Beden K; Tenbrock K; von Wrangel L; Faßhauer M; Blank N; Trauzeddel R; von Stuckrad ASL; Higgins S; Welzel T; Lutz T; Hentgen V; Foell D; Wittkowski H; Kallinich T
    Pediatr Rheumatol Online J; 2023 Sep; 21(1):108. PubMed ID: 37752496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining colchicine resistance/intolerance in patients with familial Mediterranean fever: a modified-Delphi consensus approach.
    Özen S; Sag E; Ben-Chetrit E; Gattorno M; Gül A; Hashkes PJ; Kone-Paut I; Lachmann HJ; Tsitsami E; Twilt M; Benedetti F; Kuemmerle-Deschner JB
    Rheumatology (Oxford); 2021 Aug; 60(8):3799-3808. PubMed ID: 33331943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to best practice consensus guidelines for familial Mediterranean fever: a modified Delphi study among paediatric rheumatologists in Turkey.
    Kavrul Kayaalp G; Sozeri B; Sönmez HE; Demir F; Cakan M; Oztürk K; Karadag SG; Otar Yener G; Ozdel S; Baglan E; Celikel E; Sahin N; Gezgin Yildirim D; Eker Omeroglu R; Aktay Ayaz N;
    Rheumatol Int; 2022 Jan; 42(1):87-94. PubMed ID: 33454820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of the systematic literature search as basis for the "Evidence-based treatment recommendations for familial Mediterranean fever patients with insufficient response or intolerability to colchicine" of the Society for Pediatric and Adolescent Rheumatology and the German Society for Rheumatology].
    Sahr T; Kiltz U; Weseloh C; Kallinich T; Braun J
    Z Rheumatol; 2020 Nov; 79(9):943-951. PubMed ID: 32997267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial.
    Koga T; Sato S; Miyamoto J; Hagimori N; Kawazoe Y; Arinaga K; Fukushima C; Yamamoto H; Kawakami A
    Trials; 2018 Dec; 19(1):715. PubMed ID: 30594222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Familial Mediterranean fever].
    Georgin-Lavialle S; Hentgen V; Stankovic Stojanovic K; Bachmeyer C; Rodrigues F; Savey L; Abbara S; Conan PL; Fraisse T; Delplanque M; Rouet A; Sbeih N; Koné-Paut I; Grateau G
    Rev Med Interne; 2018 Apr; 39(4):240-255. PubMed ID: 29526329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial Mediterranean fever in childhood: a single-center experience.
    Barut K; Sahin S; Adrovic A; Sinoplu AB; Yucel G; Pamuk G; Aydın AK; Dasdemir S; Turanlı ET; Buyru N; Kasapcopur O
    Rheumatol Int; 2018 Jan; 38(1):67-74. PubMed ID: 28828621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A score for predicting colchicine resistance at the time of diagnosis in familial Mediterranean fever: data from the TURPAID registry.
    Batu ED; Şener S; Arslanoglu Aydin E; Aliyev E; Bagrul İ; Türkmen Ş; Akgün Ö; Balık Z; Tanatar A; Bayındır Y; Kızıldağ Z; Torun R; Günalp A; Coşkuner T; İşgüder R; Aydın T; Haşlak F; Kasap Cüceoğlu M; Esen E; Akçay U; Başaran Ö; Pac Kısaarslan A; Akal F; Yüce D; Özdel S; Bülbül M; Bilginer Y; Aktay Ayaz N; Sözeri B; Kasapçopur Ö; Ünsal E; Özen S
    Rheumatology (Oxford); 2024 Mar; 63(3):791-797. PubMed ID: 37228026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The remarkable characteristics of the children with colchicine-resistant familial Mediterranean fever in Turkey.
    Sahin N; Ozdemir Cicek S; Pac Kisaarslan A; Poyrazoglu MH; Gunduz Z; Dusunsel R
    Mod Rheumatol; 2022 Jan; 32(1):177-185. PubMed ID: 33775204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conventional and novel therapeutic options in children with familial Mediterranean fever: A rare autoinflammatory disease.
    Poddighe D; Romano M; Garcia-Bournissen F; Demirkaya E
    Br J Clin Pharmacol; 2022 Jun; 88(6):2484-2499. PubMed ID: 34799863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A survey of resistance to colchicine treatment for French patients with familial Mediterranean fever.
    Corsia A; Georgin-Lavialle S; Hentgen V; Hachulla E; Grateau G; Faye A; Quartier P; Rossi-Semerano L; Koné-Paut I
    Orphanet J Rare Dis; 2017 Mar; 12(1):54. PubMed ID: 28302131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based recommendations for the practical management of Familial Mediterranean Fever.
    Hentgen V; Grateau G; Kone-Paut I; Livneh A; Padeh S; Rozenbaum M; Amselem S; Gershoni-Baruch R; Touitou I; Ben-Chetrit E
    Semin Arthritis Rheum; 2013 Dec; 43(3):387-91. PubMed ID: 23742958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel therapeutics for the treatment of familial Mediterranean fever: from colchicine to biologics.
    Grattagliano I; Bonfrate L; Ruggiero V; Scaccianoce G; Palasciano G; Portincasa P
    Clin Pharmacol Ther; 2014 Jan; 95(1):89-97. PubMed ID: 23867542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesothelioma in Familial Mediterranean Fever With Colchicine Intolerance: A Case Report and Literature Review.
    Talerico R; Cardillo C; De Vito F; Schinzari F; Soldato M; Giustiniani MC; Verrecchia E; Manna R
    Front Immunol; 2020; 11():889. PubMed ID: 32477360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early predictors of colchicine resistance in familial Mediterranean fever.
    Mosad Mosa D; Shokry D; Ahmed DB; Sobh A
    Mod Rheumatol; 2023 Jul; 33(4):830-835. PubMed ID: 35789271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial mediterranean fever: a fascinating model of inherited autoinflammatory disorder.
    Portincasa P; Scaccianoce G; Palasciano G
    Eur J Clin Invest; 2013 Dec; 43(12):1314-27. PubMed ID: 24117178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial Mediterranean fever, review of the literature.
    Alghamdi M
    Clin Rheumatol; 2017 Aug; 36(8):1707-1713. PubMed ID: 28624931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.
    Eroglu FK; Beşbaş N; Topaloglu R; Ozen S
    Rheumatol Int; 2015 Oct; 35(10):1733-7. PubMed ID: 26001859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological agents in familial Mediterranean fever focusing on colchicine resistance and amyloidosis.
    Sozeri B; Kasapcopur O
    Curr Med Chem; 2015; 22(16):1986-91. PubMed ID: 25760087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heterozygote forms of familial Mediterranean fever can be manifested in adults as myofacial pain syndrome].
    Meilinger A; Burger M; Peter HH
    Z Rheumatol; 2015 Aug; 74(6):533-9. PubMed ID: 25604326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.